4/2/2013

India-based makers of active pharmaceutical ingredients have made inroads in the Japanese market, with seven APIs approved in Japan for Dishman Pharmaceuticals alone. Indian generic-drug makers also hope to penetrate the market as the Japanese government promotes the use of generic drugs through tax and social security reform.

Related Summaries